Advertisements
FDA approves second generic naloxone spray
hnesich_drupal
Jun 22, 2022
The Food and Drug Administration approved the second generic naloxone nasal spray, an emergency treatment for known or suspected opioid overdose. The agency approved the first generic naloxone nasal spray in 2019.
Headline
Advertisements